Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chickenpox × fludarabine × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Sarcoma, Synovial 8 Sarcoma 8 Osteosarcoma 8 Neoplasms 7 Melanoma 7 Liposarcoma, Myxoid 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroblastoma 6 Myelodysplastic Syndromes 6 Leukemia, Myeloid, Acute 6 Dendritic Cell Sarcoma, Interdigitating 6 Rhabdomyosarcoma 5 Multiple Myeloma 5 Lymphoma, Mantle-Cell 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Burkitt Lymphoma 5 Sarcoma, Ewing 4 Ovarian Neoplasms 4 Lymphoma, Follicular 4 Leukemia, Prolymphocytic 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Lymphoma, T-Cell 3 Leukemia 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2

Interventions

fludarabine phosphate 1 fludarabine 1 Herpes Zoster Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01953900 2026-01-23

VEGAS

Baylor College of Medicine

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡